Generation of activated natural killer (A-NK) cells in patients with chronic myelogenous leukaemia and their role in the in vitro disappearance of BCR/abl-positive targets

British Journal of Haematology

Volumn 93, Issue 2, 1996, Pages 375-385

  Silla, Lucia M R ^c,d   Pincus, Steven M ^a,b   Locker, Joseph D ^a,b   Glover, Janice ^a   Elder, Elaine M ^b   Donnenberg, Albert D ^a,b   Nardi, N B ^c,d   Bryant, John ^a,b   Ball, Edward D ^a,b   Whiteside, Theresa L ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c PONTIFÍCIA UNIVERSIDADE CATÓLICA DE CAMPINAS   (Brazil)

^d FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

activated natural killer (A NK) cells; BCR abl; chronic myelogenous leukaemia; elimination of BCR abl+ targets; generation of A NK cells in CML

Indexed keywords

ALPHA INTERFERON; HYDROXYUREA; MESSENGER RNA; ONCOPROTEIN; PREDNISONE; VINCRISTINE;

ARTICLE; CELL CULTURE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; NATURAL KILLER CELL; PRIORITY JOURNAL;

EID: 9344233330     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.4991043.x     Document Type: Article

References (41)

1. Adler, A., Chervenick, P.A., Whiteside, T.L., Lotzova, E. & Herberman, R.B. (1988) Interleukin 2 induction of lymphokine activated killer (LAK) activity in the peripheral blood and bone marrow of acute leukemia patients. I. Feasibility of LAK generation in adult patients with active disease and in remission. Blood, 71, 709-716.
2. Antin, J.H. (1993) Graft-versus-leukemia: no longer an epiphenomenon. Blood, 82, 2273-22777.
3. Buttirini, A., Bortin, M.M., Seeger, R.P. & Gale, R.P. (1987) Graft versus leukemia following bone marrow transplantation: a model of immunotherapy in man. Cellular Immunotherapy of Cancer (ed. by R. L. Truitt, R. P. Gale and N. M. Bortin), p. 371. Liss, New York.
4. Buttirini, A., Keating, A., Goldman, J.M. & Gale, R.P. (1990) Autotransplants in chronic myelogenous leukaemia: strategies and results. Lancet, i, 1255-1258.
5. Caligiuri, M.A., Zmuidzinas, A., Manley, T.J., Levine, H., Smith, K.A. & Ritz, J. (1990) Functional consequences of interleukin 2 receptor expression on resting human lymphocytes: identification of a novel natural killer cell subset with high affinity receptors. Journal of Experimental Medicine, 171, 1509-1526.
6. Coulombel, L., Kalousek, D.K., Eaves, C.J., Gupta, C.M. & Eaves, A.C. (1985) Long-term marrow culture reveals chromosomally normal hematopoietic progenitor cells in patients with Philadelphia chromosome-positive chronic myelogenous leukemia. New England Journal of Medicine, 308, 1493-1498.
7. 1 cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood, 83, 3068-3076.
8. Elder, E.M., Kirkwood, J.M. & Whiteside, T.L. (1995) Characterization of human NK cells obtained from cancer patients and cultured for adoptive immunotherapy. (Abstract). Journal of Immunology, 150, 59A.
9. Fujimiya, Y., Bakke, A., Chang, W.C., Linker-Israeli, M., Udis, B., Horwitz, D. & Pattengale, P.K. (1986) Natural killer cell immunodeficiency in patients with chronic myelogenous leukemia. I. Analysis of the defect using the monoclonal antibodies HNK-1 (Leu 7) and B73.1. International Journal of Cancer, 37, 639-649.
10. Grandchamp, B., Verneuil, H.D., Beaumont, C. Chretien, S., Walter, O. & Nardmann, Y. (1987) Tissue-specific expression of porphobilinogen deaminase. European Journal of Biochemistry, 162, 105-110.
11. 1 translocation. Nature, 315, 758-761.
12. Jian, Y.-Z., Cullis, J.O., Kanfer, E.J., Goldman, J.M. & Barret, A.J. (1995) T cell and NK cell mediated graft-versus-leukemia reactivity following donor huffy coat transfusion to treat relapse after marrow transplantation for chronic myeloid leukemia. Bone Marrow Transplantation, 11, 133-138.
13. Kantarjian, H.M., Deisseroth, A., Kurzrock, R. Estrov, Z. & Talpaz, M. (1995) Chronic myelogenous leukemia: a concise update. Blood, 82, 691-703.
14. Laughlin, M., Loftus, J., Herzig, G.P., Caligiuri, T. & Caligiuri, M. (1995) Natural killer (NK) cell activity following dose intensive chemotherapy (CT). (Abstract). Blood, 82, 242a.
15. Lister, J., Pincus, S.M., Elder, E.M., Whiteside, T.L., Rybka, W.B. & Donnenberg, A.D. (1995) Adoptive immunotherapy during peripheral blood stem cell (PBSC) transplantation: amplification of natural killer cell function early after transplantation. Journal of Immunology, 150, 218A.
16. Lister, J., Rybka, W.B., Donnenberg, A.D., de Magalhaes-Silverman, M., Pomcis, S.M., Bloom, E.J., Elder, E.M., Ball, E.D. & Whiteside, T.L. (1995) Autologous peripheral blood stem cell transplantation and adoptive immunotherapy with A-NK cells in the immediate post-transplant period. Clinical Cancer Research, 1, 607-614.
17. Lotzova, E. (1988) Role of natural killer cells in defense against leukemia: therapeutic considerations. Natural Immunity and Cell Growth Regulation, 7, 170-179.
18. Murphy, W.J., Reynolds, C.W., Tiberghien, P. & Longo, D.L. (1995) Natural killer cells and bone marrow transplantation. Journal of the National Cancer Institute, 85, 1475-1482.
19. Muul, L.M., Spiess, P.J., Director, E.P. & Rosenberg, S.A. (1987) Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma. Journal of Immunology, 138, 989-995.
20. Nowell, P.C. & Hungerford, D.A. (1960) A minute chromosome in human chronic granulocytic leukemia. Science, 132, 1497
21. Pincus, S., Silla, L.M.R., Beltz, L., Donnenberg, A.D., Ball, E.D. & Whiteside, T.L. (1994) Autologous activated natural killer (A-NK) cells enhance normal human hematopoiesis. Clinical Research, 41, 365A.
22. Pross, H.F., Baines, M.G., Rubin, P., Shragge, P. & Patterson, M.S. (1981) Spontaneous human lymphocyte mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity. Journal of Cancer Immunology, 1, 51-63.
23. Rabinowich, H., Sedlmayr, P., Herberman, R.B. & Whiteside, T.L. (1991) Increased proliferation, lytic activity and purity of natural killer cells co-cultured with mitogen-activated feeder cells. Cellular Immunology, 135, 454-470.
24. Reittie, J.E., Gottlieb, D., Heslop, H.E., Leger, O., Drexler, H.G., Hazlehurst, G., Hoobrand, A.V., Prentice, H.G. & Brenner, M.K. (1989) Endogenously generated activated killer cells circulate after autologous and allogeneic marrow transplantation but not after chemotherapy. Blood, 73, 1351-1358.
25. Ringden, O. & Horowitz, M.M. (1989) Graft-versus-host leukemia reactions in humans. For the Advisory Committee of the International Bone Marrow Transplant Registry. Transplantation Proceedings 21, 2989-2992.
26. Rosenberg, S.A., Lotze, M.T., Muul, L.M., Leitman, S., Chang, A.E., Ettinghausen, S.E., Matory, Y.L., Skibber, J.M., Shiloni, E., Vetto, J.T., Seipp, C.A., Simpson, C. & Reichert, C.M. (1985) Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin 2 to patients with metastatic cancer. New England Journal of Medicine, 313, 1485-1492.
27. Rosenberg, S.A., Spiess, P. & Lafreniere, R. (1986) A new approach to adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science, 233, 1318-1321.
28. Rowley, J.D. (1973) A new consistent chromosome abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa staining. Nature, 243, 145-147.
29. Sedlmayr, P., Rabinowich, H., Winkelstein, A., Herberman, R.B. & Whiteside, T.L. (1992) Generation of adherent lymphokine activated killer (A-NK) cells from patients with acute myelogenous leukaemia. British Journal of Cancer, 65, 222-228.
30. Shtivelman, E., Lifshitz, B., Gale, R.P. & Canaani, E. (1985) Fused transcript of ABL and BCR genes in chronic myelogenous leukaemia. Nature, 315, 550-554.
31. Shtivelman, E., Lifshitz, B., Gale, R.P., Roe, B.A. & Canaani, E. (1986) Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene. Cell, 47, 277-284.
32. Verfaillie, C., Kay, N., Miller, W. & McGlave, P. (1990) Diminished A-LAK cytotoxicity and proliferation accompany disease progression in chronic myelogenous leukemia. Blood, 75, 401-408.
33. Verfaillie, C., Miller, W., Kay, N. & McGlave, P. (1989) Adherent lymphokine-activated killer cells in chronic myologenous leukemia: a benign cell population with potent cytotoxic activity. Blood, 74, 793-797.
34. Verma, U.N., Bagg, A., Brown, E. & Mazumder, A. (1994) Interleukin-2 activation of human bone marrow in long-term cultures: an effective strategy for purging and generation of antitumor cytotoxic effectors. Bone Marrow Transplantation, 13, 115-123.
35. Vitolo, D., Vujanovic, N., Rabinowich, H., Schlesinger, M., Herberman, R.B. & Whiteside, T.L. (1993) Rapid interleukin-2 induced adherence of human natural killer (NK) cells. II. Expression of mRNA for cytokines and IL2 receptors in adherent NK cells. Journal of Immunology, 151, 1926-1937.
36. Vujanovic, N.L., Rabinowich, H., Lee, Y.J., Jost. L., Herberman, R.B. & Whiteside, T.L. (1993) Distinct phenotypic and functional characteristics of human natural killer cells obtained by rapid interleukin 2-induced adherence to plastic. Cellular Immunology, 151, 133-157.
37. Vujanovic, N.L., Yasumura, S., Hirabayashi, H., Lin, W.C., Watkins, S., Herberman, R.B. & Whiteside, T.L. (1995) Antitumor activities of human IL2-activated natural killer (A-NK) cells in solid tumor tissues. Journal of Immunology, 154, 281-289.
38. Whiteside, T.L., Bryant, J., Day, R. & Herberman, R.B. (1990) Natural killer cytotoxicity in the diagnosis of immune dysfunction: criteria for a reproducible assay. Journal of Clinical Laboratory Analysis, 2, 102-114.
39. Whiteside, T.L. & Herberman, R.B. (1995) Role of natural killer cells in immune surveillance of cancer. Current Opinion in Immunology, 7, 704-710.
40. Yasumura, S., Hirabayashi, H., Schwartz, D.R., Toso, J.F., Johnson, J.T., Herberman, R.B. & Whiteside, T.L. (1993) Human cytotoxic T-cell lines with restricted specificity for squamous cell carcinoma of the head and neck. Cancer Research, 53, 1461-1468.
41. Yasumura, S., Lin, W., Hirabayashi, H., Vujanovic, N.L., Herberman, R.B. & Whiteside, T.L. (1994) Immunotherapy of liver metastases of human gastric carcinoma with IL2-activated natural killer cells. Cancer Research, 54, 3808-3816.